Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
Applied Genetic Technologies Corporation (AGTC) stock rallied over 3.83% intraday to trade at $0.81 a share on NASDAQ. The stock opened with a gain of 3.85% at $0.82 and touched an intraday high of $0.837, rising 3.85% against the last close of $0.78. The stock went to a low of $0.794 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-05 | $0.82 | $0.837 | $0.794 | $0.81 | 164,117 |
2022-07-01 | $0.78 | $0.79 | $0.77 | $0.78 | 139,700 |
2022-06-30 | $0.75 | $0.783 | $0.73 | $0.77 | 226,100 |
2022-06-29 | $0.76 | $0.79 | $0.745 | $0.761 | 288,400 |
2022-06-28 | $0.737 | $0.758 | $0.7 | $0.746 | 280,600 |
2022-06-27 | $0.725 | $0.75 | $0.7 | $0.735 | 332,800 |
2022-06-24 | $0.82 | $0.84 | $0.58 | $0.617 | 1,234,400 |
2022-06-23 | $0.824 | $0.85 | $0.786 | $0.824 | 124,400 |
2022-06-22 | $0.81 | $0.85 | $0.8 | $0.821 | 693,600 |
2022-06-21 | $0.83 | $0.845 | $0.81 | $0.816 | 179,200 |
Employees-
Beta1.66
Sales or Revenue500 Thousands
5Y Sales Change-59.80%
Fiscal Year Ends2021-06-29
SectorHealth Care
IndustryBiotechnology
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida.
Applied Genetic Technologies Corporation (NASDAQ: AGTC) stock price is $0.81 as of the last check on Tuesday, July 5. During the trading session, AGTC stock reached the peak price of $0.837 while $0.794 was the lowest point it dropped to.
The NASDAQ listed AGTC is part of Biotechnology industry that operates in the broader Health Care sector. Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials.
Ms. Susan B. Washer
Pres, CEO & Director
Mr. Stephen W. Potter
VP & Chief Bus. Officer
Dr. William W. Hauswirth
Co-Founder & Member of Ophthalmology Scientific Advisory Board
Dr. Terence R. Flotte M.D.
Co-Founder
AGTC stock traded closed the last session at $0.81, which is $0.03 or 3.83% lower than its previous close of $0.78. AGTC's current trading price is 39.66% lower than its 52-week high of $4.15 where as its distance from 52-week low of 0.58% is -80.48%.
Number of AGTC employees currently stands at -. AGTC operates from 14193 NW 119th Terrace, Suite 10, Alachua, FL 32615, United States.
Official Webiste of $AGTC is: https://agtc.com
AGTC could be contacted at AGTC operates from 14193 NW 119th Terrace, Suite 10, Alachua, FL 32615, United States, or at phone #386 462 2204 and can also be accessed through its website.
AGTC stock volume for the day was 162,542 shares while in the previous session number of AGTC shares traded was 164,117 . The average number of AGTC shares traded daily for last 3 months was 435.17 Thousands.
The percentage change in AGTC stock occurred in the recent session was 3.83% while the dollar amount for the price change in AGTC stock was $0.03.
In the recent session, the day high for AGTC stock was $0.837 while the low for AGTC stock touched on the day was $0.794.
The market value of AGTC currently stands at 40.61 Million with its latest stock price at $0.81 and 50.73 Million of its shares outstanding.